SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005; 100: 27082716.
    Direct Link:
  • 2
    Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693700.
  • 3
    Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 13941403.
  • 4
    Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228: 479490.
  • 5
    Shah SA, Tan JC, McGilvray ID, Cattral MS, Cleary SP, Levy GA, et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 2006; 81: 16331639.
  • 6
    Reddy MS, Manas DM. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 2007; 83: 367368.
  • 7
    Roberts JP. Tumor surveillance—what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation. Liver Transpl 2005; 11: S45S46.
  • 8
    Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005; 5: 795804.
  • 9
    Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation 2006; 81: 15321541.
  • 10
    Kondili LA, Lala A, Gunson B, Hubscher S, Olliff S, Elias E, et al. Primary hepatocellular cancer in the explanted liver: outcome of transplantation and risk factors for HCC recurrence. Eur J Surg Oncol 2007; 33: 868873.
  • 11
    Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 10801086.
  • 12
    Soderdahl G, Backman L, Isoniemi H, Cahlin C, Hockerstedt K, Broome U, et al. A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma. Transpl Int 2006; 19: 288294.
  • 13
    Bernal E, Montero JL, Delgado M, Fraga E, Costan G, Barrera P, et al. Adjuvant chemotherapy for prevention of recurrence of invasive hepatocellular carcinoma after orthotopic liver transplantation. Transplant Proc 2006; 38: 24952498.
  • 14
    United Network for Organ Sharing. Policy 3.6.4.4: Liver transplant candidates with hepatocellular carcinoma (HCC). Available at: http://www.unos.org/policiesandbylaws2/policies/pdfs/policy_8.pdf. Accessed April 2007.
  • 15
    HamiltonSR, AaltonenLA, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000.
  • 16
    Regalia E, Fassati LR, Valente U, Pulvirenti A, Damilano I, Dardano G, et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg 1998; 5: 2934.
  • 17
    Park JW, Lee KW, Kim SJ, Choi SH, Heo JS, Kwon CH, et al. Outcome of patients with recurrent hepatocellular carcinoma in liver transplantation. Transplant Proc 2006; 38: 21212122.
  • 18
    Larson, AM. The epidemiology of hepatocellular carcinoma in HCV. Curr Hepat Rep 2005; 4: 145152.
  • 19
    Perkins JD. Early detection of hepatocellular carcinoma. Liver Transpl 2007; 13: 11961197.
  • 20
    Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, et al. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl 2007; 13: 543551.
  • 21
    Marubashi S, Dono K, Nagano H, Sugita Y, Asaoka T, Hama N, et al. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation. Transpl Int 2007; 20: 576582.
  • 22
    Shan YS, Hsieh YS, Lin P. Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection. World J Surg 2007; 31: 11221129.
  • 23
    Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004; 10: 534540.
  • 24
    Perkins JD. Recurrent hepatocellular carcinoma is a problem we need to tackle. Liver Transpl 2007; 13: 10571058.